Anastomotic Complications After Esophagectomy: Frequency, Prevention, and Management [43 SKF]

Introduction

• Esophagectomy: Mainstay treatment for esophageal cancer since 1901.
• Improved Outcomes: Major complication rate of 33.1% and mortality rate of 3.1% (STS National Database).
• Anastomotic Complications:
  • Pose a significant technical challenge.
  • Negatively impact postoperative recovery.
  • Understanding and managing these complications is crucial.

Surgical Techniques for Esophageal Resection

Common Approaches

• Ivor Lewis Esophagectomy (ILE): Intrathoracic anastomosis.
• Transhiatal Esophagectomy (THE): Cervical anastomosis.
• McKeown or Tri-Incisional Esophagectomy (TIE): Cervical anastomosis.
• Thoracoabdominal Esophagectomy (TAE): Intrathoracic anastomosis.

Reconstruction Conduits

• Stomach: Most commonly used.
• Alternatives:
  • Pedicled Colonic or Small Bowel Grafts.
  • Small Bowel Free Grafts (rare).

Anastomotic Methods

• Handsewn Techniques:
  • Double-layer sutures.
  • Continuous vs. interrupted sutures.
  • Various suture types.
• Mechanical Stapling Devices:
  • Circular staplers.
  • Linear staplers.

Anastomotic Leak

• Significance:
  • "Achilles Heel" of esophagectomy.
  • Mortality Risk: Threefold increase; up to 60% mortality.
  • Impact on Recovery:
    • Longer hospital stays.
    • Delayed oral feeding.
    • Increased risk of reoperation.
  • Oncologic Outcomes:
    • Reduced overall and disease-free survival.
    • Increased risk of cancer recurrence.

Classification and Incidence

Incidence Variability

• Range: 0% to 35%.
• Factors:
  • Variable definitions of leaks.
  • Different diagnostic tools.
  • Timing of evaluation (30 vs. 90 days).
  • Anastomotic location (cervical vs. thoracic).

Standardized Definitions

• IMAGINE Group:
  • Leak Definition: Defect in surgical join between two hollow viscera.

• Esophagectomy Complications Consensus Group (ECCG):

  Anastomotic Leak Types:

  • Type I: Local defect; no change in therapy or treated medically.
  • Type II: Localized defect; requires interventional but not surgical therapy.
  • Type III: Localized defect; requires surgical therapy.

  Conduit Necrosis Types:

  • Type I: Focal necrosis; non-surgical treatment.
  • Type II: Focal necrosis; surgical therapy without esophageal diversion.
  • Type III: Extensive necrosis; requires conduit resection with diversion.

Lerut et al. Classification

• Grade I/II: Minor leaks; clinically occult or low-risk.
• Grade III/IV: Major leaks; high mortality rates (60%-90%).

Risk Factors

Patient Factors

• Malnutrition:
  • Hypoalbuminemia.
  • Significant weight loss.
• Comorbidities:
  • Heart failure.
  • Hypertension.
  • Renal insufficiency.
• Neoadjuvant Therapy:
  • Controversial risk factor.
  • Dependent on radiation dose.

Esophageal Characteristics

• Lack of Serosal Layer:
  • Increased fragility.
  • Decreased suture security.
• Location in Thorax:
  • Negative intrathoracic pressure promotes leakage.

Surgical Factors

• Conduit Perfusion:
  • Critical for anastomotic healing.
  • Anastomosis often in the most ischemic area.
• Anastomotic Tension:
  • Impairs blood supply.
  • Leads to ischemia.
• Conduit Choice:
  • Whole Stomach: Better blood supply but risk of distention.
  • Gastric Tube: Less distention; may have impaired blood flow.
  • Colonic Interposition: More anastomoses; leak incidence debated.
• Anastomotic Location:
  • Cervical: Higher leak rates (2%-26%); leaks often less severe.
  • Thoracic: Lower leak rates (0%-9.3%); leaks may be more severe.
• Anastomotic Technique:
  • Stapled vs. Handsewn: No significant difference in leak rates.
• Surgical Approach:
  • Minimally Invasive Esophagectomy:
    • Fewer complications.
    • Decreased length of hospital stay.

Prevention of Leak

Preoperative Optimization

• Nutritional Support: Correct malnutrition.
• Medical Management: Optimize comorbid conditions.
• Minimize Steroid Use.

Intraoperative Strategies

• Assessing Perfusion:
  • Visual Inspection: Color, temperature.
  • Doppler Signals: Limited to macrocirculation.
  • Fluorescence Imaging:
    • Evaluates microcirculation.
    • Correlates weaker perfusion with leaks.
• Ischemic Preconditioning:
  • Embolization of gastric vessels preoperatively.
  • Limited success in human studies.
• Technical Considerations:
  • Minimize Trauma: Protect collateral vessels.
  • Avoid Tension: Ensure proper conduit length and positioning.

Postoperative Care

• Prevent Gastric Distention:
  • Use nasogastric tubes.
  • Administer promotility agents.
• Pyloric Drainage Procedures:
  • Pyloromyotomy or pyloroplasty.
• Pharmacologic Agents:
  • Prostaglandin E1: Increases blood flow (no proven clinical benefit).

Diagnosis of Leak

Clinical Presentation

• Conduit Necrosis:
  • Presents within 48-72 hours.
  • Catastrophic sepsis.
• Subtle Signs:
  • Unexplained low-grade fever.
  • Tachycardia.
  • Leukocytosis.
• Specific Indicators:
  • Bilious output in drains.
  • Wound erythema or fluctuance (cervical leaks).

Diagnostic Tools

• Contrast Esophagram:
  • Routine postoperative imaging.
  • Detects clinically silent leaks.
• Computed Tomography (CT):
  • More sensitive than esophagram.
  • Preferred when leak is suspected.
• Endoscopy:
  • Confirms leaks.
  • Guides intervention.
  • Safe post-esophagectomy.

Management

General Principles

• Supportive Care:
  • Intensive monitoring.
  • Optimize perfusion to the conduit.
  • Broad-spectrum antibiotics.
  • Nutritional support (preferably enteral).
• Drainage:
  • Drain collections near the anastomosis.

Cervical Leaks

• Small, Contained Leaks:
  • Conservative Management:
    • Nothing by mouth.
    • Monitor healing.
  • Possible Interventions:
    • Antibiotics.
    • Wound opening for drainage.
• Larger Leaks with Erythema:
  • Open surgical wound for drainage.
  • Consider suture closure or stenting.
• Persistent or Worsening Cases:
  • Assess for conduit necrosis.
  • Surgical exploration may be necessary.

Intrathoracic Leaks

• Contained Collections:
  • Percutaneous drainage if stable.
• Unstable Patients with Sepsis:
  • Surgical intervention:
    • Washout and drainage.
    • Debridement.
    • Possible anastomotic revision.

Endoscopic Interventions

• Stenting:
  • Indications: Leaks involving <30% of anastomotic circumference.
  • Types: Covered self-expanding stents.
  • Challenges:
    • Stent migration.
    • Inadequate coverage.
    • Erosion into surrounding structures.
• Endoluminal Vacuum Therapy:
  • Technique:
    • Sponge placed endoscopically.
    • Closes defect and drains collection.
    • Vacuum applied via intranasal route.
  • Emerging Alternative:
    • Promising results in leak management.

---

Conduit Necrosis

Incidence and Significance

• Incidence: Ranges from 0.5% to 10.4%.
• Severity:
  • Includes subclinical ischemia to frank necrosis.
  • Mortality Rate: May exceed 90%.
• Consequences:
  • Development of strictures.
  • Anastomotic leaks requiring reoperation.

Risk Factors

• Surgical Technique Issues:
  • Improper creation or manipulation of the gastric tube.
  • Twisting of the stomach conduit.
  • Tight hiatal opening.
• Patient Factors:
  • Radiation Therapy: Causes fibrotic reactions reducing microvascular blood supply.
  • Low Cardiac Output: Perioperative hypotension.
  • Malnutrition.
  • Previous Upper Abdominal Surgery.
  • Peptic Ulcer Disease.

Presentation and Diagnosis

• Clinical Presentation:
  • Severe sepsis within the first week postoperatively.
  • Unexplained tachycardia.
  • Leukocytosis.
  • Rapid clinical decompensation.
• Diagnostic Tools:
  • Upper Gastrointestinal Contrast Study:
    • May show anastomotic leak.
    • Possible cobblestoning of the mucosa.
  • Computed Tomography (CT) with Oral Contrast:
    • Identifies effusions.
    • Normal results do not exclude ischemia.
  • Endoscopy:
    • Preferred method for assessing conduit viability.
    • Safe within the first postoperative week.
  • Endoscopic Grading System (Table 43.3):
    • Grade 1: Dusky bluish mucosa near anastomosis.
    • Grade 2: Partial anastomotic disruption.
    • Grade 3: Complete circumferential breakdown.
    • Grade 4: Necrotic black mucosa throughout the conduit.

Management

• Nonoperative Management:
  • For small leaks with viable conduit.
  • Possible stenting.
• Surgical Intervention:
  • Required for necrotic conduits.
  • Procedures:
    • Emergent exploration via thoracoscopy, thoracotomy, or neck incision.
    • Conduit resection.
    • Creation of an end esophagostomy.
    • Placement of venting gastrostomy and feeding jejunostomy.
  • Considerations:
    • Preserve as much esophageal length as possible.
    • Delay reconstruction until sepsis resolves.
    • Reconstruction Options:
      • Colonic interposition.
      • Jejunal transfer.

Anastomotic Stricture

Incidence

• Reported Incidence: 10% to 40%.
• Note: Actual incidence may be higher due to underreporting.

Causes and Risk Factors

• Anastomotic Leak: Major contributing factor.
• Anastomotic Technique:
  • Two-layer Handsewn Anastomoses: Higher stricture rates.
  • Circular End-to-End Stapled Anastomoses: Higher stricture rates.
  • Semimechanical End-to-Side Anastomosis:
    • Larger cross-sectional area.
    • Lower stricture rates (35% vs. 48% for handsewn).
• Endoscopic Findings Predictive of Stricture:
  • Anastomotic leak.
  • Visible stitches.
  • Mucosal ulceration involving >50% of the anastomosis.

Diagnosis and Management

• Symptoms:
  • Patient-reported dysphagia.
• Diagnosis:
  • Endoscopy: Assesses stricture severity.
• Management:
  • Endoscopic Dilation:
    • Savary Dilators.
    • Pneumatic Dilators.
    • Effective in 93% of cases.
  • Pharmacologic Therapy:
    • Proton-pump inhibitors to prevent recurrence.
• Resistance to Treatment:
  • Strictures from severe ischemia may be resistant to dilation.
• Late Presentation:
  • Raises suspicion for tumor recurrence.

Conduit-Airway Fistula

Incidence and Significance

• Incidence: Rare, 0.04% to 0.3%.
• Severity:
  • Potentially life-threatening.
  • Requires rapid identification and management.

Causes

• Neoadjuvant Therapy:
  • Strong correlation due to tissue injury and ischemia.
• Anastomotic Leak:
  • Leakage leads to tissue necrosis and erosion into the airway.
• Intraoperative Tracheobronchial Injury:
  • Rare but can contribute to fistula formation.
• Ischemia from Extensive Dissection:
  • Around the trachea during surgery.
• Stent Erosion:
  • After leak management.
• Endoscopic Dilation:
  • Can cause fistula after treating anastomotic stricture.
• Prolonged Intubation:
  • Cuff-induced tracheal necrosis.

Presentation and Diagnosis

• Symptoms:
  • Cough with oral intake.
  • Recurrent pneumonia.
  • Severe cases may present with mediastinitis.
• Diagnostic Tools:
  • Radiologic Studies with Oral Contrast:
    • May not detect small fistulas.
  • Endoscopy:
    • Preferred for localization.
    • May miss small openings due to mucosal folds.
  • Bronchoscopy:
    • Best combined with endoscopy for accurate assessment.

Management

• Conservative Treatment:
  • For patients with mild symptoms.
  • Trial of nothing by mouth and antibiotics.
  • Reassess if no improvement in 4-6 weeks.
• Endoscopic Interventions:
  • Fibrin Glue Application.
  • Hemostatic Clips.
  • Mesh Plugs.
  • Stenting:
    • Temporizing measure to control contamination.
• Surgical Repair:
  • Preferred Approach:
    • Repair the anastomosis.
    • Close the airway defect.
    • Interpose vascularized soft tissue between suture lines.
  • Severe Cases:
    • Conduit excision.
    • Esophagostomy with delayed reconstruction.
    • Reconstruction Options:
      • Colonic interposition via the substernal route.
      • Jejunal interposition.

---